Molecular and Clinical Aspects of Targeting the VEGF Pathway in Tumors

por Korpanty, Grzegorz, Sullivan, Laura A., Smyth, Elizabeth, Carney, Desmond N., Brekken, Rolf A.
Publicado 2010

Enhanced Heme Function and Mitochondrial Respiration Promote the Progression of Lung Cancer Cells

por Hooda, Jagmohan, Cadinu, Daniela, Alam, Md Maksudul, Shah, Ajit, Cao, Thai M., Sullivan, Laura A., Brekken, Rolf, Zhang, Li
Publicado 2013

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer

por Dineen, Sean P, Sullivan, Laura A, Beck, Adam W, Miller, Andrew F, Carbon, Juliet G, Mamluk, Roni, Wong, Henry, Brekken, Rolf A
Publicado 2008

r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction

por Sullivan, Laura A., Carbon, Juliet G., Roland, Christina L., Toombs, Jason E., Nyquist-Andersen, Mari, Kavlie, Anita, Schlunegger, Kyle, Richardson, James A., Brekken, Rolf A.
Publicado 2010